Personalized Cancer Vaccines Advance Toward Clinical Use in Comprehensive Review
A literature review evaluates how artificial intelligence and diverse delivery platforms are advancing personalized neoantigen cancer vaccines into clinical practice.
A literature review evaluates how artificial intelligence and diverse delivery platforms are advancing personalized neoantigen cancer vaccines into clinical practice.
A scientific review highlights how microproteins translated from previously overlooked short open reading frames regulate leukemogenesis and present novel targets ...
MIT researchers have developed a modular bacteriophage-based nanoparticle platform that allows for the precise control of antigen density, enabling the ...
A computational analysis of public sequencing data predicts a private neoantigen repertoire and copy number driven cell-surface targets in malignant ...
An ex vivo study shows tailored PEI-PLGA nanovaccines functionalized with poly(I:C) enhanced neoantigen-specific T-cell activation in cells from melanoma patients.
New research in Nature finds that 33 of 34 lupus patients carried neutrophils with RNA splicing mutations producing neoantigens that ...
Researchers report an immune-enhanced boron neutron capture therapy platform that achieved high intratumor boron-10 levels and a model-estimated 99.6 percent ...
Phase 3 trial results presented at ESMO 2026 show that adding personalized mRNA vaccine intismeran to pembrolizumab reduces melanoma recurrence ...
A mouse breast cancer study found that CD40-stimulated B cells recruited CD8+ T cells into tumors, influenced their organization and ...
A Dana-Farber-led Immunity study shows that p53-mutant cancers can evade T-cell detection through several mechanisms, while laboratory ERAP1 inhibition restores ...
A 2026 review finds that TCR-engineered T cells have entered early clinical testing for hepatocellular carcinoma, but safety, antigen heterogeneity ...
MSIPep combines immunopeptidomics, transcriptomics and deep learning to identify and computationally prioritize candidate tumor peptides in leukemia and solid-tumor datasets.
A new multi-omics framework proposes that tumor immunogenicity emerges only when epigenetic permissiveness, DNA damage response configuration and immune activation ...
A new study in Cancer Discovery shows that circulating tumor DNA and immune cells drawn from a simple blood sample ...
A landmark Perspective in Nature Reviews Cancer argues that the cancer dark proteome — thousands of uncharacterized proteins from non-canonical ...
A metal–organic framework nanovaccine co-delivering tumour antigens and STING agonists induced systemic tumour regression, immune memory and synergy with radiotherapy ...
A new analysis suggests HIV impairs the immune system's ability to recognize tumor neoantigens in non-small cell lung cancer without ...
A new review in Materials Today Bio proposes a bottleneck-first framework for evaluating antigen delivery platforms in therapeutic cancer vaccines, ...
In recent years, the intersection of genomic instability and immune response has emerged as a compelling area of study, shedding ...
In the relentless battle against cancer, T cells have emerged as pivotal warriors within the adaptive immune system. These specialized ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.